Disruptive Pharma (DPHA.ST) traded up 3.81 % during a 24 hours period ending at 05:42 AM Central Europe on Wednesday 28th. One Disruptive Pharma stock can currently be bought for about SEK 1.24 on popular exchanges. Current supply of Disruptive Pharma stocks is 44.6 mn. Disruptive Pharma has a current market capitalization of SEK 48.6 mn and approximately SEK 7 k worth of Disruptive Pharma was traded on exchanges in the last 24 hours. Since last month end, Disruptive Pharma has traded -10.66 % down. Simple moving average of last 200 days is at SEK 1.44. The highest price of past 52 weeks was recorded at SEK 2.35 on 01/16/2026. 52 weeks low was at SEK 0.88 on 04/22/2026.
Here is how related stocks have performed in the past 24 hours:
Fragbite (FRAG.ST) traded down -1.9 % and now trades at SEK 6.14. Current market capitalisation for Fragbite is SEK 51.1 mn. Current price/earnings ratio for Fragbite is 0.85.
Goodbye Kansas (GBK.ST) traded flat 0 % and now trades at SEK 1.32. Goodbye Kansas has a market capitalisation of SEK 49.2 mn.
Redsense Medical (R0Z.F) traded flat 0 % and now trades at EUR 0.27. Current market capitalisation for Redsense Medical is EUR 4.5 mn.
Neola Medical (NEOLA.ST) traded up 1.92 % and now trades at SEK 0.54. Current market capitalisation for Neola Medical is SEK 57.5 mn.
About Disruptive Pharma
A1M Pharma AB (publ) is a health care biotechnology company based in Lund, Sweden. The company specializes in developing and commercializing medical applications for the diagnosis and treatment of pre-eclampsia and kidney damage. Their main product is ROSGard, a drug candidate that uses alpha-1-microglobulin protein to protect and repair damaged kidney tissues. A1M Pharma AB (publ) collaborates with Antaros Medical to conduct a study in humans undergoing radiation therapy of neuroendocrine tumours.